胞漿型磷脂酶A2(PLA2G4)單克隆抗體
Monoclonal Antibody to Cytosolic Phospholipase A2 (PLA2G4)
c-PLA2; cPLA2; PLA2G4A; Phospholipase A2, Cytosolic; Phospholipase A2,Group IV(Cytosolic,Calcium-Dependent); Phosphatidylcholine 2-acylhydrolase; Lysophospholipase
- 編號MAB624Hu22
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)C10
- Ig亞型 IgG2a Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原RPB624Hu02-胞漿型磷脂酶A2(PLA2G4)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/mL
- 且適物種-
- 應用IHC
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 655¥ 1529¥ 2184¥ 5460¥ 21840
- 欲了解實際交易價格和更多情況，請與當?shù)亟涗N商聯(lián)系!
產品包裝(模擬)
產品包裝(模擬)
DAB staining on IHC-P; Sample: Human Breast cancer Tissue Primary Ab: 30μg/ml Mouse Anti-Human PLA2G4 Antibody Control: Used PBS instead of primary antibody Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
DAB staining on IHC-P;
Sample: Human Liver Tissue
Primary Ab: 30μg/ml Mouse Anti-Human PLA2G4 Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
DAB staining on IHC-P;
Sample: Human Kidney Tissue
Primary Ab: 30μg/ml Mouse Anti-Human PLA2G4 Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
DAB staining on IHC-P;
Sample: Human Pancreas Tissue
Primary Ab: 30μg/ml Mouse Anti-Human PLA2G4 Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對PLA2G4的小鼠單克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別PLA2G4。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB624Hu02 | 胞漿型磷脂酶A2(PLA2G4)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB624Hu01 | 胞漿型磷脂酶A2(PLA2G4)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB624Hu01 | 胞漿型磷脂酶A2(PLA2G4)多克隆抗體 | WB; IHC |
| PAB624Hu02 | 胞漿型磷脂酶A2(PLA2G4)多克隆抗體 | WB; IHC |
| LAB624Hu71 | 胞漿型磷脂酶A2(PLA2G4)多克隆抗體(生物素標記) | IHC |
| MAB624Hu21 | 胞漿型磷脂酶A2(PLA2G4)單克隆抗體 | WB; IHC |
| MAB624Hu22 | 胞漿型磷脂酶A2(PLA2G4)單克隆抗體 | IHC |
| FAB624Hu02 | 抗胞漿型磷脂酶A2(PLA2G4)單克隆抗體 | FCM |
| FAB624Hu04 | 抗胞漿型磷脂酶A2(PLA2G4)單克隆抗體 | FCM |
| FAB624Hu06 | 抗胞漿型磷脂酶A2(PLA2G4)單克隆抗體 | FCM |
參考文獻
| 雜志 | 參考文獻 |
| BIOMEDICINE & PHARMACOTHERAPY | The synergistic mechanism of total saponins and flavonoids in Notoginseng? Safflower pair against myocardial ischemia uncovered by an integrated?…[Pubmed: 32739736] |